ABOUT US

A global leader in innovative genomic
technology and diagnostic tests.


What’s new at Agendia?

Get the latest updates on our company and products, as well as new developments in genomic science.

News

In the News

Who We Are

Our purpose, our story our vision. Hear how Agendia fits into the evolving landscape of technology and cancer care.

Two women reading about genomic breast cancer results

Latest Data

Agendia Presents New Data Demonstrating MammaPrintโ€™s Clinical Utility in Treatment Decisions for Ultra-Low Risk Breast Cancer Patients [โ€ฆ]

I Am Here breast cancer illustration

Patient News

Agendia and artist Andrea Caceres go โ€œbeyond the mammogramโ€ in a portrait series illustrating people touched by breast cancer.

News

Media Releases

PROMIS study findings presented at SABCS 2019

December 23rd, 2019|

PRESS RELEASE New Data Compare Genomic Profiling Results for Premenopausal Women with Early-Stage Breast Cancer ย  IRVINE, CALIF., U.S., and AMSTERDAM, NETHERLANDS, December 12, 2019 โ€“ Agendia, Inc., a world leader in precision oncology for Read More

Agendia Presents New Data on the Biological Characteristics of Patients within Extreme Low Risk and High Risk MammaPrint Subgroups at the European Society for Medical Oncology (ESMO)

September 28th, 2019|

ย  PRESS RELEASE IRVINE, CALIF., U.S., and AMSTERDAM, NETHERLANDS โ€“ 29 September 2019 โ€“ Agendia, Inc., a world leader in precision oncology for breast cancer, will present new data from their on-going clinical research at Read More